October 24, 2012
Santen Pharmaceutical, the top player in the ophthalmology field, is going on the offensive in the market for glaucoma and retinal disease treatments. Buoyed by sharp growth in its new portfolio, including its proprietary Tapros Ophthalmic Solution (tafluprost), the company...read more